Skip to main content
Clinical Trials/NCT03319992
NCT03319992
Completed
Phase 2

Robotic Assisted Task-Oriented Rehabilitation of Upper Limb for Chronic Stroke Patients

Scuola Superiore Sant'Anna di Pisa1 site in 1 country26 target enrollmentJuly 20, 2016

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Cerebrovascular Accident (CVA)
Sponsor
Scuola Superiore Sant'Anna di Pisa
Enrollment
26
Locations
1
Primary Endpoint
Change in Fugl-Meyer Assessment (FMA( Score
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The aim of this study is to evaluate the effects of an assisted rehabilitation treatment through a robotic exoskeleton device on the functional recovery in a group of patients with hemiparesis from lesion of the first motor neuron (post-stroke), compared with a group of patients subjected to a conventional rehabilitation treatment. The patients enrolled in the study are chronic stroke injured with right hemiparesis of moderate to severe degree, by the system injury pyramid, never undergoing rehabilitation treatment with robots.

Registry
clinicaltrials.gov
Start Date
July 20, 2016
End Date
November 30, 2018
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Scuola Superiore Sant'Anna di Pisa
Responsible Party
Principal Investigator
Principal Investigator

Antonio Frisoli

Prof, Office of Research and Development

Scuola Superiore Sant'Anna di Pisa

Eligibility Criteria

Inclusion Criteria

  • diagnosis of a first-ever left hemisphere ischemic or hemorrhagic stroke at least 6 months prior to entry into the study;
  • minimum ability for shoulder humeral elevation;
  • upper-extremity motor function Fugl-Meyer (FM) score ≥ 15(out of 66);
  • absence of neurological or muscular disorders that interfere with neuromuscular function;
  • absence of severe cognitive deficits that would limit patients' ability to complete the study;
  • minimum score of 2 in the Modified Ashworth Scale;
  • not participating in any experimental rehabilitation or drug studies at the same time
  • no previous experience with robotic treatments.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Change in Fugl-Meyer Assessment (FMA( Score

Time Frame: baseline and 6 weeks

The null hypothesis tested in this study was the change in motor function domain of the upper extremity portion of the Fugl-Meyer assessment in the Robotic Group (Robotic Treatment) would be the same as the one obtained by the Control Group (Conventional Treatment). The FMA outcome is further divided and analyzed in terms of sub-items. In particular, the motor FMA score is divided into proximal (shoulder and elbow movement, 36 points) and distal (hand and wrist movement, 24 points) sub-items.

Secondary Outcomes

  • Functional scale: Bimanual Activity Test (BAT)(baseline and 6 weeks)
  • Modified Ashworth (MA) scale(baseline and 6 weeks)
  • Robotic kinesiological assessment of movement: Execution Time(At end of each session, during 6 weeks of enrollment in treatment)
  • Robotic kinesiological assessment of movement: Smoothness index(At end of each session, during 6 weeks of enrollment in treatment)

Study Sites (1)

Loading locations...

Similar Trials